Great Basin Scientific Inc. (fka GBSNQ)

[roger that]

http://www.grandviewresearch.com/industry-analysis/blood-testing-market

The global blood testing market size was valued at USD 51.5 billion in 2015. The need for reducing length of stay at hospitals and reduction in durations of contact between patients and concerned physicians coupled with the rise in demand for outpatient services have increased the demand for blood testing services.

Shift in focus of healthcare providers from therapy towards early detection of diseases, especially in fields of cardiovascular and endocrinology medicine, has poised the industry to witness lucrative growth during the forecast period. Other notable drivers include the introduction of various innovative solutions that enable faster and accurate diagnosis by using plasma or serum screening methods. Furthermore, rising inclination of the physicians towards blood-based diagnosis in order to provide rapid and reliable results is also anticipated to influence growth through to 2024

Increasing levels of patient awareness about self-testing and home diagnostic tests are expected to enhance market adoption of relevant products in the aforementioned settings, especially with patients who have chronic diseases such as diabetes have a long term need for portable and reliable self-diagnostic capabilities.

Moreover, healthcare practitioners have been observed to be increasingly more reliant on point of care diagnostics enabled medical devices and consumables owing to the reduced turnaround times and comparable testing accuracy as that of laboratory tests. Consequent growth in demand for these tests is expected to provide lucrative avenues for growth over the forecast period. Industry participants are also involved in the provision of online results via e-mail and facilitation of disease diagnosis through reduction in the number of visits to the pathology laboratory